Correct. The real question (and the reason I made the subordinate question you answered a quiz) is whether GILD’s assertion vis-à-vis non-compliance in the TMC278 phase-3 studies holds water. I’m inclined to think that it doesn’t. Do you agree?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.